VANCOUVER, BC, June 3, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to provide a summary of ...

Pheast Therapeutics, a clinical-stage biotechnology company developing novel therapies to unleash the power of macrophages on aggressive, difficult-to-treat cancers, today announced that the U.S. Food ...

Vanqua Bio, a clinical-stage biopharmaceutical company, announced that the company will present interim Phase 1 data for its ...

Macrophages and other immune cells are the natural frontline immune warriors of our body, defending the body against invading ...

Researchers at the UVA School of Medicine found blocking a brain-defense molecule in mice prevented memory loss and other ...

A new way of thinking about Alzheimer’s disease has yielded a discovery that could be the key to stopping the cognitive ...

Researchers review current advances in trained immunity—a promising avenue for preventing infectious diseases in chickens ...

Known for supporting both the innate and adaptive immune systems, vitamin D has long been used to help fend off illness. But ...

A decades-old TB vaccine turned cancer therapy may unlock new immunotherapies by reprogramming immune cell development in the ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...